União Europeia - português - EMA (European Medicines Agency)

co.don gmbh - esferóides de condrócitos associados à matriz autóloga humana - doenças da cartilagem - outras drogas para distúrbios do sistema músculo-esquelético - reparação de defeitos de cartilagem articular sintomática do côndilo femoral e da rótula do joelho (international cartilage repair society [icrs] grau iii ou iv) com defeitos de até 10 cm2 em adultos.

União Europeia - português - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - linfoma, mantle-cell - agentes antineoplásicos - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

União Europeia - português - EMA (European Medicines Agency)

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - imunológicos para suidae - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. outro contribuidor chave para a mancha de javali, skatole, também pode ser reduzido como um efeito indireto. os comportamentos agressivos e sexuais (de montagem) também são reduzidos. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).

União Europeia - português - EMA (European Medicines Agency)

holostem s.r.l - células epiteliais corneanas humanas autólogas expandidas ex vivo que contêm células estaminais - stem cell transplantation; corneal diseases - oftalmológicos - tratamento de pacientes adultos com deficiência de células estaminais limbo moderadas a graves (definidos pela presença de neovascularização corneana superficial em pelo menos dois quadrantes corneanos, com comprometimento corneano central e gravidade visual severa), unilateral ou bilateral, devido a ocular física ou química queima. um mínimo de 1-2 mm2 de limbo não danificado é necessário para biópsia.

União Europeia - português - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - agentes antineoplásicos - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

União Europeia - português - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - doença pulmonar, obstrução crônica - medicamentos para obstrutiva, doenças das vias respiratórias, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

União Europeia - português - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - doença pulmonar, obstrução crônica - medicamentos para obstrutiva, doenças das vias respiratórias, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

União Europeia - português - EMA (European Medicines Agency)

novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - oftalmológicos - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

sifi s.p.a. - dexametasona + netilmicina - colírio, solução em recipiente unidose - 0.3 mg/0.3 ml + 0.9 mg/0.3 ml - dexametasona, fosfato sódico 1.32 mg/ml ; netilmicina, sulfato 4.55 mg/ml - dexamethasone and antiinfectives - n/a - duração do tratamento: curta ou média duração

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

sifi s.p.a. - dexametasona + netilmicina - colírio, solução em recipiente unidose - 0.3 mg/0.3 ml + 0.9 mg/0.3 ml - dexametasona, fosfato sódico 1.32 mg/ml ; netilmicina, sulfato 4.55 mg/ml - dexamethasone and antiinfectives - n/a - duração do tratamento: curta ou média duração